View
72
Download
2
Embed Size (px)
Citation preview
Greening the Health Sector
Dr. Christoph HamelmannRegional Practice Leader HIV, Health and Development
UNDP Europe and Central Asia
CIS Pharmaceutical Forum
Moscow, Russia, 5 January 2013
Pharmaceuticals andClimate Change
cc c
Likely Temperature Increaseby GHG Emission Pathways
Energy Intensity (Energy consumption per unit GDP 2011, ENERDATA)
Countries Energy Intensity World Major Country Ranking (highest 4)
Uzbekistan 0.633 1
Ukraine 0.436 2
Kazakhstan 0.399 3
Russia 0.346 4
Countries Unconditional Pledge Conditional Pledge Current GHG Emissions(MtCO2e 2010)
Armenia - Submitted policy actions 11
Azerbaijan - - 50
Belarus Reduction 8 % below 1990 level by 2020 - 150
Kazakhstan Reduction 15 % below 1990 level by 2020 - 318
Kyrgyzstan - - ?
Moldova Reduction 25 % below 1990 level by 2020 - 11
Russia Reduction 15 % below 1990 level by 2020 Reduction 25 % below 1990 level by 2020
2510
Tajikistan - Submitted policy actions 15
Uzbekistan - - 174
Turkmenistan - - 87
Ukraine Reduction 20 % below 1990 level by 2020 - 397
GHG Emission Reduction PledgesCIS Countries
Health Sector in the ECIS Region
• Accounts for 7.5 % of GDP• Technology intensive with significant
consumption of resources, associated with environmental pollution and degradation
• Accounts for an estimated 4.2 % of greenhouse gases (GHG) in the ECIS region
• Up to 25 % of these GHG can be reduced within short-term, more through long-term measures
• Reductions have also direct positive impact on life-years saved
Ministerial European Environment and Health Task Force Meeting, Bled / Slovenia 2011
NHS Carbon Footprint Breakdown 2010
+ others
European Ministerial Environment & Health Task Force
Fifth Ministerial Conferenceon Environment and Health
Parma 2010
53 member states, including all CIS countries
Sector Guidance on Carbon Foot-Printing
• Cross-sectoral partnership• Standardized quantification of
the GHG inventory of pharmaceutical products certified by international GHG protocol
• Identification of hot spots throughout the product life cycle
• Focus on minimizing carbon footprint for producers, buyers and users of pharmaceutical products http://www.sdu.nhs.uk/pharma-md
Marginal Abatement Costs
Gaining Efficiencies – Reducing GHG EmissionsLessons Learnt From Pharma-Industry
Stay competitive!
ESA
Economic Commission for EuropeReport Regional Preparatory Meeting
Public procurement47. Sustainable public procurement was supported as a first critical step to further the green economy at the national as well as the sub-national level. Concrete progress was proposed in the form of sustainable public procurement targets that could be met by an increasing number of countries over the years.
Leadership and Innovations